Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis

Type 2 innate lymphoid cells (ILC2) potentiate immune responses, however, their role in mediating adaptive immunity in cancer has not been assessed. Here, we report that mice genetically lacking ILC2s have significantly increased tumour growth rates and conspicuously higher frequency of circulating...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sci Rep
Autori principali: Saranchova, Iryna, Han, Jeffrey, Zaman, Rysa, Arora, Hitesh, Huang, Hui, Fenninger, Franz, Choi, Kyung Bok, Munro, Lonna, Pfeifer, Cheryl G., Welch, Ian, Takei, Fumio, Jefferies, Wilfred A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5811448/
https://ncbi.nlm.nih.gov/pubmed/29440650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-20608-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi